Directive 65/65/EEC1


Directive 65/65/EEC1

Directive 65/65/EEC1 was the first European pharmaceutical directive. The directive was a reaction to the Thalidomide tragedy in the early 1960s, when thousands of babies were born with deformities as a result of their mothers taking thalidomide during pregnancy. The directive aimed to establish and maintain a high level of protection for public health in Europe.Fact|date=April 2007 The idea behind the directive was that no medicinal product should ever again be marketed in the European Union without prior authorisation.Fact|date=April 2007

See also

* EudraLex
* Kefauver Harris Amendment
* Regulation of therapeutic goods
* European Medicines Agency

References

* Maio G., "On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation", Dtsch Med Wochenschr. 2001 Oct 19;126(42):1183-6.
* Shah RR., Thalidomide, drug safety and early drug regulation in the UK, Adverse Drug React Toxicol Rev. 2001 Dec;20(4):199-255.

External links

* [http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31965L0065:EN:HTML Directive 65/65/EEC1]
* [http://www.euractiv.net/en/health/new-medicines-legislation/article-117531 New medicines legislation] (overview)


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Directive 2001/20/EC — or Clinical Trials Directive of 4 April 2001, of the European Parliament and of the Council on the approximation of the laws, Regulations and administrative provisions of the Member States relating to implementation of good clinical practice in… …   Wikipedia

  • Directive 93/41/EEC — of 14 June 1993 on the approximation of national measures relating to the placing on the market of high technology medicinal products, particularly those derived from biotechnology. The Directive offered two routes for authorising medicinal… …   Wikipedia

  • Directive 75/318/EEC — of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of the European Union …   Wikipedia

  • Directive 75/319/EEC — of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of the European Union …   Wikipedia

  • Directive 2001/83/EC — of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. The Directive dealt with the disparities between certain nationalprovisions, in particular between provisions… …   Wikipedia

  • Directive 2005/28/EC — The Directive 2005/28/EC or Good Clinical Practice Directive, of 8 April 2005 of the European Parliament and of the Council, lays down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for …   Wikipedia

  • Clinical Trials Directive — The Clinical Trials Directive (Officially Directive 2001/20/EC of 4 April 2001, of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States relating to… …   Wikipedia

  • Regulation of therapeutic goods — The regulation of therapeutic goods, that is drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are… …   Wikipedia

  • List of European Union directives — The following is an incomplete thematic list of European Union directives :Anti discrimination measures*Council Directive 2000/43/EC of 29 June 2000 implementing the principle of equal treatment between persons irrespective of racial or ethnic… …   Wikipedia

  • EudraLex — is the collection of rules and regulations governing medicinal products in the European Union.VolumesEudraLex consists of 10 volumes: *Concerning Medicinal Products for Human use: **Volume 1 Pharmaceutical Legislation. **Volume 2 Notice to… …   Wikipedia